Literature DB >> 2231936

Evaluation of tumor progression by repeated fine needle biopsies in prostate adenocarcinoma: modal deoxyribonucleic acid value and cytological differentiation.

J Adolfsson1, B Tribukait.   

Abstract

Repeated fine needle aspiration biopsies of the prostate were taken during a period of 24 months or more from 84 patients with untreated prostate cancer. Serial followup regarding modal deoxyribonucleic acid values and cytological differentiation of the tumor cells was possible in 72 and 78 patients, respectively. During followup the modal deoxyribonucleic acid values in the tumor cells changed towards an increased aneuploidy in 17 patients and the cytological differentiation decreased in 18. These findings of a change in modal deoxyribonucleic acid values and cytological differentiation of prostate cancer cells during the course of untreated patients support the concept of a gradual dedifferentiation of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2231936     DOI: 10.1016/s0022-5347(17)39755-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Molecular and cellular markers for metastatic prostate cancer.

Authors:  C W Rinker-Schaeffer; W B Isaacs; J T Isaacs
Journal:  Cancer Metastasis Rev       Date:  1993-03       Impact factor: 9.264

2.  Diagnosis, prognosis and management of incidentally found prostate cancer.

Authors:  P J Davidson
Journal:  Urol Res       Date:  1993-01

3.  Change in prostate cancer grade over time in men followed expectantly for stage T1c disease.

Authors:  Todd B Sheridan; H Ballentine Carter; Wenle Wang; Patricia B Landis; Jonathan I Epstein
Journal:  J Urol       Date:  2008-01-22       Impact factor: 7.450

4.  Quantitative pathology: historical background, clinical research and application of nuclear morphometry and DNA image cytometry.

Authors:  Abdelbaset Buhmeida
Journal:  Libyan J Med       Date:  2006-09-20       Impact factor: 1.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.